Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan. - Wikidata - awgldk - TriplyDB

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

http://www.wikidata.org/entity/Q37448980

about

Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review Systematic review of the economic value of diarrheal vaccines Cost-effectiveness of hepatitis A vaccination in Indonesia.Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales.Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.

P2860

Q28072167-4CF65F0E-C59B-4873-AF2E-C11928CABE4D Q33577996-1892787B-716C-4180-91E7-C482C24614FC Q35450372-8CF9BE0F-00E2-4FE8-871E-518F1D953C6A Q38547247-88E0C1DD-B499-4379-8D1D-916D78C92366 Q38619905-88E9DF76-1AF7-4EDC-A12B-A8C9A3B62595

P2860

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

http://www.wikidata.org/entity/Q37448980

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@en

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@nl

type

label

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@en

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@nl

prefLabel

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@en

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@nl

P1433

Q37448980-C8996227-5E2E-4718-8597-569B4714AD7D

P1476

Q37448980-6153D793-AC06-4D07-8B3C-162DF75A1F25

P2093

Q37448980-245BD3AE-A901-4835-9B67-8019DE33D198

Q37448980-8F25A4DB-20FB-47C4-88A3-5E1217EA5BD9

Q37448980-A7825750-7F83-42D6-8F02-87380CFCA955

Q37448980-D804DE1A-D6C5-45D5-844E-83D5A785B58A

P2860

Q37448980-164825A5-834D-43C0-92D0-EB8E2C571F69

Q37448980-18A88B6A-9D82-485A-8287-88614FC6B0D7

Q37448980-2D54C742-15BF-48A8-A963-AB2A003231B3

Q37448980-2FAC7381-91A1-41D6-A7E0-80D13F7BD58A

Q37448980-34108C52-46F6-42A5-BA96-434D202FF612

Q37448980-3582CDB5-6A86-4393-A28C-4FF600C5FCDB

Q37448980-3D0AC9B0-143D-4CD2-9FC5-D8D8DB996610

Q37448980-46269524-E67C-46A6-8E83-A812B5431C6A

Q37448980-46FF19F8-253B-4AF0-80AE-42C917CC755C

Q37448980-49DA4AB1-E60D-4133-90F5-08AD8020CE3D

P304

Q37448980-DED93AB1-3EB6-4AA1-8869-2ECB9E79CF65

P31

Q37448980-5DF23C56-11CC-4579-84CD-D33D6BC6088F

P356

Q37448980-DCA2B5BC-AB3F-4621-8985-D2EFC6BF315A

P433

Q37448980-42F1B09C-BBD3-4C88-803C-5BE3E1296158

P478

Q37448980-5A80F1C2-A442-4A91-949E-639E9F6530FF

P50

Q37448980-0A36D430-4616-4850-A66A-4F47C8BAFCAC

P577

Q37448980-E950C669-24FD-4D79-980D-F00E65F80875

P5875

Q37448980-A541D1AD-1FF6-440D-A845-2C6A29531605

P698

Q37448980-BDFF3007-2A62-4DBA-8CA9-9FC260428F7B

P921

Q37448980-279DC852-9B79-41E1-811C-9E4211491B27

P932

Q37448980-5626DA1A-DA10-40E1-A9C8-7A563732A1A7

P356

P1433

Emerging Infectious Diseases

P1476

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

@en

P2093

Ajnagul Kuatbaeva

http://www.w3.org/2001/XMLSchema#string

Birgitte Freiesleben de Blasio

http://www.w3.org/2001/XMLSchema#string

Elmira Flem

http://www.w3.org/2001/XMLSchema#string

Ivar Sønbø Kristiansen

http://www.w3.org/2001/XMLSchema#string

P2860

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Effectiveness of monovalent and pentavalent rotavirus vaccine.

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.

Duration of protection of pentavalent rotavirus vaccination in Nicaragua.

Rotavirus infection in infants as protection against subsequent infections.

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

Oral rotavirus vaccines: how well will they work where they are needed most?

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.

P304

29-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID2001.130019

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259498528

http://www.w3.org/2001/XMLSchema#string

P698

24378188

http://www.w3.org/2001/XMLSchema#string

P921

An Chasacstáin

P932

3884708

http://www.w3.org/2001/XMLSchema#string